Table 1.
Cell counts of controls analyzed by in situ padlock probe technology.
Gene | Total Cell Count |
CellCollector
Healthy Controls |
PBMC Healthy Controls | PC Cell Lines | |||||||||
Ctrl 1 | Ctrl 2 | Ctrl 3 | Ctrl 4 | Ctrl 5 | Ctrl 6 | PC-3 | VCaP | ||||||
# cells | # cells | % | # cells | % | # cells | % | # cells | % | |||||
N.A. | N.A. | N.A. | N.A. | 33,855 | 100.00 | 34,544 | 100.00 | 4573 | 100.00 | 2200 | 100.00 | ||
KLK3 | 0 RCPs/cell | N.A. | N.A. | N.A. | N.A. | 33,855 | 100.00 | 34,544 | 100.00 | 4573 | 100.00 | 2181 | 99.14 |
1 RCP/cell | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 18 | 0.82 | |
2 RCPs/cell | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 1 | 0.05 | |
3 RCPs/cell | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | |
>3 RCPs/cell | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | |
AR-V7 | 0 RCPs/cell | N.A. | N.A. | N.A. | N.A. | 33,593 | 99.23 | 34,298 | 99.29 | 4511 | 98.64 | 411 | 18.68 |
1 RCP/cell | 5 | 9 | 6 | 6 | 262 | 0.77 | 246 | 0.71 | 62 | 1.36 | 451 | 20.50 | |
2 RCPs/cell | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 423 | 19.23 | |
3 RCPs/cell | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 296 | 13.45 | |
>3 RCPs/cell | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 619 | 28.14 | |
AR-FL | 0 RCPs/cell | N.A. | N.A. | N.A. | N.A. | 33,486 | 98.91 | 34,213 | 99.04 | 4502 | 98.45 | 51 | 2.32 |
1 RCP/cell | 6 | 4 | 1 | 3 | 360 | 1.06 | 327 | 0.95 | 70 | 1.53 | 58 | 2.64 | |
2 RCPs/cell | 0 | 1 | 0 | 0 | 9 | 0.03 | 4 | 0.01 | 1 | 0.02 | 79 | 3.59 | |
3 RCPs/cell | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 121 | 5.50 | |
>3 RCPs/cell | 0 | 0 | 0 | 0 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 1891 | 85.95 |
This table summarizes the number and percentage of cells with 0, 1, 2, 3, or >3 RCPs/cell for KLK3, AR-V7, and AR-FL. Shaded rows represent the cut-off used for the identification of CTCs in patient samples. Total cell number was not counted on CellCollectors (N.A. = not available). VCaP cells were used as positive control. PBMC: peripheral blood mononuclear cells; RCP: rolling circle product; PC: prostate cancer; Ctrl: control.